Blue Faery’s Blog
When Promising Treatments Are Out of Reach: Bridging the Gap in Cancer Care
Dr. Ildiko Csiki explains barriers to investigational cancer treatments, the role of compassionate use, and why patients should explore options early.
From Hospice to Hope: One Patient's Journey Through Compassionate Use
Will Monlux shares how compassionate use changed his stage IV liver cancer journey and why early advocacy and investigational treatment awareness matter.
Beyond Clinical Trials: Understanding the Challenges of Compassionate Use
Dr. Richard Finn explains compassionate use, barriers to investigational cancer treatments, and how patients with liver cancer can explore expanded access.
When Standard Treatments Aren't Enough: A Sister's Fight for Options
Andrea Wilson Woods describes a sister's search for liver cancer treatment options reveals the challenges of compassionate use, patient advocacy, and honoring a loved one's wishes.
From Doctor to Liver Cancer Caregiver
Dr. George Monlux shares his experience as a physician and father after his son Will received a stage 4 liver cancer diagnosis, and why families should ask about clinical trials, compassionate use, and second opinions.
Liver Cancer Changed Vicky Wright's Life Overnight
ER nurse Vicky Wright never expected to become a liver cancer patient. Her story follows advanced HCC, transplant, recurrence, and resilience.
Liver Cancer Survival and the Life-Saving Power of Self-Advocacy
After her mother's liver cancer diagnosis, Nicole became a caregiver, advocate, and source of hope during years of treatment, transplant, and recurrence.
Liver Cancer Caregiving: A Story of Hope, Surgery, and Hospice
Learn how Jennifer Schumacher navigated a stage 4 liver cancer diagnosis and her own cancer battle at the same time. Discover vital tips on advocacy, surgery recovery, and choosing hospice with dignity.
Why Liver Cancer Survival Is Improving
Learn how Dr. Maen Abdelrahim is transforming liver cancer care. Discover the importance of early detection, the role of "Tumor Boards," and how new immunotherapy treatments are providing hope for Stage 4 patients.